Investing Sanofi shares slide as FDA delays MS drug decision and late-stage trial disappoints December 15, 2025 Share Share on Facebook Share on Twitter Pinterest Email The post Sanofi shares slide as FDA delays MS drug decision and late-stage trial disappoints appeared first on Invezz Author Website Prev Post Apple stock seen entering ‘AI revolution’ in 2026: here’s what it may look like December 13, 2025 Next Post Here’s why this FTSE 100 Index stock jumped ~380% in 2025 December 15, 2025 Related Posts Xpeng prepares Hong Kong IPO for flying car unit as China backs air mobility January 12, 2026 Heineken shares fall as CEO to step down; analysts mixed on strategic outlook January 12, 2026 From LUV to HOG to RACE: do quirky stock tickers influence performance? January 11, 2026
